Renal AA amyloidosis: survey of epidemiologic and laboratory data from one nephrology centre (Q33404657)

26 July 2017

Renal AA amyloidosis: survey of epidemiologic and laboratory data from one nephrology centre (English)

1 reference

26 July 2017

1 reference

3

V Tesar

1 reference

26 July 2017

Z Potysová

1

1 reference

26 July 2017

M Merta

2

1 reference

26 July 2017

E Jancová

4

1 reference

26 July 2017

E Honsová

5

1 reference

26 July 2017

R Rysavá

6

1 reference

26 July 2017

31 January 2009

1 reference

International Urology and Nephrology

26 July 2017

1 reference

26 July 2017

41

1 reference

26 July 2017

941-945

1 reference

26 July 2017

4

1 reference

First report of systemic reactive (AA) amyloidosis in a patient with the hyperimmunoglobulinemia D with periodic fever syndrome

26 July 2017

1 reference

12 December 2020

Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis.

1 reference

12 December 2020

Clinical and therapeutic aspects of AA amyloidosis

1 reference

12 December 2020

In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis

1 reference

12 December 2020

The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994-2000.

1 reference

12 December 2020

Shift in the incidence of rheumatoid arthritis toward elderly patients in Finland during 1975-1990.

1 reference

12 December 2020

Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis

1 reference

12 December 2020

Presentation, survival and prognostic markers in AA amyloidosis

1 reference

12 December 2020

Clinical and genetic aspects of the hereditary periodic fever syndromes

1 reference

12 December 2020

Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein

1 reference

12 December 2020

Secondary systemic amyloidosis: response and survival in 64 patients

1 reference

12 December 2020

Where has secondary amyloid gone?

1 reference

12 December 2020

The heparin/heparan sulfate-binding site on apo-serum amyloid A. Implications for the therapeutic intervention of amyloidosis.

1 reference

12 December 2020

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

1 reference

12 December 2020

Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy

1 reference

12 December 2020

Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness

1 reference

12 December 2020

A one-center experience with pediatric percutaneous renal biopsy and histopathology in Ankara, Turkey

1 reference

12 December 2020

Current therapeutic possibilities in primary and secondary amyloidosis and our experience with 31 patients

1 reference

12 December 2020

Clinical aspects of systemic amyloid diseases.

1 reference

12 December 2020

Pathology, diagnosis and pathogenesis of AA amyloidosis

1 reference

12 December 2020

No improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases -- data from the Finnish national registry for kidney diseases

1 reference

12 December 2020

10.1007/S11255-009-9524-2

Identifiers

DOI

1 reference

26 July 2017

1 reference